Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia. | BMC Cancer | 2022 | 35379200 | PubTator, text mining | PubMed |
| The High Expression of Minichromosome Maintenance Complex Component 5 Is an Adverse Prognostic Factor in Lung Adenocarcinoma. | Biomed Res Int | 2022 | 35360518 | PubTator, text mining | PubMed |
| Genomic diversity and post-admixture adaptation in the Uyghurs. | Natl Sci Rev | 2022 | 35350227 | PubTator, text mining | PubMed |
| Evaluation of Early Biomarkers of Atherosclerosis Associated with Polychlorinated Biphenyl Exposure: An in Vitro and in Vivo Study. | Environ Health Perspect | 2022 | 35349355 | PubTator, text mining | PubMed |
| RAB2A promotes cervical cancer progression as revealed by comprehensive analysis of HPV integration and proteome in longitudinal cervical samples. | Clin Transl Med | 2022 | 35343109 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| Treatment of Resectable Gallbladder Cancer. | Cancers (Basel) | 2022 | 35326566 | PubTator, text mining | PubMed |
| Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. | World J Gastrointest Oncol | 2022 | 35321281 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity. | Nat Commun | 2022 | 35301290 | PubTator, text mining | PubMed |
| A genome-wide association study of outcome from traumatic brain injury. | EBioMedicine | 2022 | 35301180 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Ageing-Relevant Subtypes Associated With Different Tumorigenesis and Tumor Microenvironment in Prostate Cancer. | Front Mol Biosci | 2022 | 35265669 | PubTator, text mining | PubMed |
| Genetic susceptibility to hereditary non-medullary thyroid cancer. | Hered Cancer Clin Pract | 2022 | 35255942 | PubTator, text mining | PubMed |
| [Epigenetic changes in the promoter of the fragile histidine triad (FHIT) gene in human sebocytes under the influence of in vitro culture]. | Ophthalmologie | 2022 | 35254487 | PubTator, text mining | PubMed |
| System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets. | Int J Biol Markers | 2022 | 35254116 | PubTator, text mining | PubMed |
| Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. | Front Pharmacol | 2022 | 35250573 | PubTator, text mining | PubMed |
| Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer. | Mol Ther Oncolytics | 2022 | 35229032 | PubTator, text mining | PubMed |
| The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35223517 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives. | Pathogens | 2022 | 35215076 | PubTator, text mining | PubMed |
| Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. | J Pers Med | 2022 | 35207722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=17